SV2B
Basic information
Region (hg38): 15:91099950-91302565
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SV2B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 32 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 2 | 1 |
Variants in SV2B
This is a list of pathogenic ClinVar variants found in the SV2B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-91226295-G-C | not specified | Uncertain significance (May 16, 2024) | ||
15-91226303-G-A | not specified | Uncertain significance (Jun 23, 2021) | ||
15-91226324-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
15-91226325-G-A | not specified | Uncertain significance (Jan 02, 2024) | ||
15-91226331-A-G | not specified | Uncertain significance (Feb 27, 2024) | ||
15-91226348-G-C | not specified | Uncertain significance (Aug 13, 2021) | ||
15-91226396-A-G | not specified | Uncertain significance (Apr 13, 2022) | ||
15-91226418-G-A | not specified | Uncertain significance (Jun 04, 2024) | ||
15-91226420-A-G | not specified | Uncertain significance (Nov 07, 2022) | ||
15-91226500-C-A | not specified | Uncertain significance (Jul 19, 2023) | ||
15-91226533-G-C | not specified | Uncertain significance (Oct 06, 2021) | ||
15-91226579-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
15-91226600-T-C | not specified | Uncertain significance (May 20, 2024) | ||
15-91226603-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
15-91226610-G-A | not specified | Uncertain significance (Apr 07, 2022) | ||
15-91251905-A-T | not specified | Uncertain significance (May 26, 2022) | ||
15-91251917-G-A | not specified | Likely benign (Mar 17, 2023) | ||
15-91252371-T-C | not specified | Uncertain significance (Oct 18, 2021) | ||
15-91252421-C-T | not specified | Uncertain significance (May 06, 2022) | ||
15-91252491-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
15-91252515-A-G | not specified | Uncertain significance (Mar 19, 2024) | ||
15-91258450-C-T | not specified | Uncertain significance (Aug 02, 2023) | ||
15-91258457-A-G | not specified | Uncertain significance (Feb 06, 2024) | ||
15-91266640-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
15-91266658-G-A | SV2B-related disorder | Likely benign (Jul 28, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SV2B | protein_coding | protein_coding | ENST00000394232 | 12 | 201360 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000570 | 1.00 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.16 | 327 | 392 | 0.835 | 0.0000209 | 4560 |
Missense in Polyphen | 104 | 146.42 | 0.71028 | 1745 | ||
Synonymous | 0.825 | 139 | 152 | 0.915 | 0.00000885 | 1269 |
Loss of Function | 3.20 | 13 | 32.7 | 0.397 | 0.00000165 | 368 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000206 | 0.000206 |
Ashkenazi Jewish | 0.000399 | 0.000397 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000794 | 0.0000791 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000502 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Probably plays a role in the control of regulated secretion in neural and endocrine cells. {ECO:0000250}.;
- Pathway
- ECM-receptor interaction - Homo sapiens (human);Disease;Toxicity of botulinum toxin type A (BoNT/A);Toxicity of botulinum toxin type D (BoNT/D);Toxicity of botulinum toxin type F (BoNT/F);Uptake and actions of bacterial toxins;Neurotoxicity of clostridium toxins;Infectious disease;Toxicity of botulinum toxin type E (BoNT/E)
(Consensus)
Recessive Scores
- pRec
- 0.177
Intolerance Scores
- loftool
- 0.468
- rvis_EVS
- -1.17
- rvis_percentile_EVS
- 5.99
Haploinsufficiency Scores
- pHI
- 0.745
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.648
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.734
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sv2b
- Phenotype
- normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; growth/size/body region phenotype; cellular phenotype;
Gene ontology
- Biological process
- neurotransmitter transport;chemical synaptic transmission;transmembrane transport
- Cellular component
- acrosomal vesicle;plasma membrane;synaptic vesicle;membrane;integral component of membrane;cell junction;synaptic vesicle membrane;neuron projection
- Molecular function
- protein binding;transmembrane transporter activity